8
ꢀꢀꢀꢀꢁꢀE. Wolińska: Chiral oxazoline ligands with two azaheteroaromatic rings
chromatography (CH Cl /MeOH, 30:1) and crystallized from ethanol; 2-[Bis(5,6-diphenyl-1,2,4-triazin-3-yl)amino]-3-[(4S)-4-isopropyl-
2
2
2
0
yield 35% (76 mg); mp 158–160°C; [α]D ꢀ=ꢀ +1.5 (c 0.52, CH Cl ); IR 4,5-dihydro-1,3-oxazol-2-yl]pyridine 1-oxide (13c)ꢁCompound
2
2
(
ZnSe): 2.960, 2926, 2899, 2881, 1643, 1627, 1516, 1442, 1396, 1049, 765, was prepared from 3-[(4S)-4-isopropyl-4,5-dihydro-1,3-oxazol-2-yl]
-1 1
6
94 cm ; H NMR (CDCl ): δ 12.65 (s, 1H), 8.59 (dd, 1H, J ꢀ=ꢀ 1.9 Hz, J ꢀ=ꢀ pyridine-2-amine 1-oxide (12c) (243 mg, 1.1 mmol), purified by silica
3
4
.8 Hz), 8.13 (dd, 1H, J ꢀ=ꢀ 1.9 Hz, J ꢀ=ꢀ 7.7 Hz), 7.62–7.64 (m, 2H), 7.54–7.56 gel chromatography (CH Cl /MeOH, 30:1) and crystallized from hex-
2 2
2
0
(
(
m, 2H), 7.40–7.29 (m, 6H), 7.00 (dd, 1H, J ꢀ=ꢀ 4.8 Hz, J ꢀ=ꢀ 7.7 Hz), 4.46 anes/EtOAc; yield 42% (143 mg); mp 142–144°C; [α]D ꢀ=ꢀ -21.8 (c 0.61,
dd, 1H, J ꢀ=ꢀ 8.2 Hz, J ꢀ=ꢀ 9.3 Hz), 4.26–4.20 (m, 1H), 4.13 (t, 1H, J ꢀ=ꢀ 8.1 CH Cl ); IR (KBr): 3057, 2958, 1651, 1519, 1489, 1398, 1367, 1282, 1064,
2
2
-1 1
Hz), 1.90–1.82 (m, 1H), 1.14 (d, 3H, J ꢀ=ꢀ 6.7 Hz), 1.01 (d, 3H, J ꢀ=ꢀ 6.7 Hz); 759, 696 cm ; H NMR (CDCl ): δ 8.43 (dd, 1H, J ꢀ=ꢀ 1.2 Hz, J ꢀ=ꢀ 6.8 Hz),
3
13
C NMR (CDCl ): δ 162.7, 158.8, 156.6, 153.0, 152.7, 151.7, 138.4, 136.7, 7.95 (dd, 1H, J ꢀ=ꢀ 1.2 Hz, J ꢀ=ꢀ 8.8 Hz), 7.54–7.47 (m, 9H), 7.40–7.33 (m,
3
1
1
36.6, 131.1, 130.6, 129.9, 129.4, 129.0, 128.9, 117.0, 109.2, 73.2, 70.5, 33.5, 10H), 7.24–7.20 (m, 2H), 4.19 (t, 1H, J ꢀ=ꢀ 7.6 Hz), 3.94–3.85 (m, 2H), 1.52–
1
3
9.0, 18.9. Anal. Calcd for C H N O (436.51): C, 71.54; H, 5.54; N, 19.25. 145 (m, 1H), 0.64 (d, 3H, J ꢀ=ꢀ 6.8 Hz), 0.60 (d, 3H, J ꢀ=ꢀ 6.8 Hz); C NMR
2
6
24
6
Found: C, 71.51; H, 5.61; N, 19.18.
(CDCl ): δ 159.0, 158.9, 158.3, 156.7, 156.6, 153.9, 153.8, 145.7, 141.2, 135.6,
35.5, 135.4, 130.5, 130.4, 130.1, 130.0, 129.4, 129.3, 129.2, 129.1, 128.4,
,6-Diphenyl-3-{3-[(4R)-4-benzyl-4,5-dihydro-1,3-oxazol-2-yl] 128.2, 128.1, 127.2, 126.8, 123.9, 72.9, 70.0, 32.4, 18.3, 18.0. HRMS (ESI).
3
1
5
+
pyridin-2-yl}amino-1,2,4-triazine (2d)ꢁThe product was obtained Calcd for C H N O ([M+H] ): m/z 684.2830. Found: m/z 684.2836.
41
34
9
2
from 3-[(4R)-4-benzyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine
6d) after 18 h of heating as a yellow solid, purified by column chro-
matography (CH Cl /MeOH, 30:1) and crystallized from ethanol; yield
(
2
2
Procedure for the reaction of 3-chloro-5,6-diphenyl-
,2,4-triazine (7b) with (4,5-dihydro-1,3-oxazol-2-yl)
pyridine-2-amine 1-oxides in the absence of K CO
2
0
3
7% (89 mg); mp 168–170°C; [α]D ꢀ=ꢀ -24.6 (c 0.53, CH Cl ); IR (ZnSe):
2 2
1
-1
1
3
061, 2887, 1643, 1604, 1496, 1440, 1411, 1346, 1047, 767, 694 cm ; H
NMR (CDCl ): δ 12.38 (s, 1H), 8.58 (dd, 1H, J ꢀ=ꢀ 1.8 Hz, J ꢀ=ꢀ 5.0 Hz), 8.12
2
3
3
(
dd, 1H, J ꢀ=ꢀ 1.8 Hz, J ꢀ=ꢀ 7.8 Hz), 7.63–7.58 (m, 2H), 7.57–7.56 (m, 2H),
7
.44–7.24 (m, 9H), 7.21–7.17 (m, 2H), 7.00 (dd, 1H, J ꢀ=ꢀ 5.0 Hz, J ꢀ=ꢀ 7.6 Hz), The mixture of 3-chloro-5,6-diphenyl-1,2,4-triazine (7b, 267 mg,
4
.79–4.71 (m, 1H), 4.41 (t, 1H, J ꢀ=ꢀ 8.2 Hz), 4.16 (t, 1H, J ꢀ=ꢀ 8.2 Hz), 3.25 1 mmol) and 3-[(4S)-4-alkyl/aryl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-
(
dd, 1H, J ꢀ=ꢀ 6.8 Hz, J ꢀ=ꢀ 14.0 Hz), 2.87 (dd, 1H, J ꢀ=ꢀ 6.8 Hz, J ꢀ=ꢀ 14.0 Hz); 2-amine 1-oxide (12a or 12b, 1.1 mmol) in DMF (7 mL) was heated at
13
C NMR (CDCl ): δ 162.4, 158.0, 156.0, 152.3, 152.1, 151.1, 137.9, 137.5, 50°C for 24 h. The solvent was evaporated under vacuum and the pro-
3
1
36.0, 135.9, 130.4, 130.0, 129.3, 128.8, 128.6, 128.4, 128.3, 126.6, 116.6, ducts were isolated by silica gel chromatography (CH Cl /MeOH, 30:1).
2
2
+
1
08.6, 71.1, 67.9, 41.7. HRMS (ESI). Calcd for C H N O ([M+H] ): m/z
3
0
25
6
4
85.2084. Found: m/z 485.2088.
2-(5,6-Diphenyl-1,2,4-triazin-3-ylamino)-3-[(4S)-4-tert-butyl-
4
,5-dihydrooxazol-2-yl]pyridine 1-oxide (3a)ꢁCompound was
prepared from 3-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]pyri-
dine-2-amine 1-oxide (12a, 259 mg, 1.1 mmol); yield 15% (105 mg); mp
Procedure for the reaction of 3-chloro-5,6-diphenyl-
,2,4-triazine (7b) with (4,5-dihydro-1,3-oxazol-2-yl)
pyridine-2-amine 1-oxides in the presence of K CO
0
9
8–100°C; [α]D2 ꢀ=ꢀ -30.1 (c 1.27, CH Cl ); IR (SnZe): 3061, 2955, 1645,
2
2
1
-1
1
1
504, 1360, 1190, 1058, 696 cm ; H NMR (CDCl ): δ 10.59 (br s, 1H),
3
2
3
8.40 (dd, 1H, J ꢀ=ꢀ 1.2 Hz, J ꢀ=ꢀ 6.4 Hz), 7.81 (dd, 1H, J ꢀ=ꢀ 1.2 Hz, J ꢀ=ꢀ 8.0
Hz), 7.55–7.51 (m, 4H), 7.40–7.29 (m, 6H), 7.08 (dd, 1H, J ꢀ=ꢀ 6.4 Hz, J ꢀ=ꢀ
1
3
A mixture of 3-chloro-5,6-diphenyl-1,2,4-triazine (7b, 267 mg, 1 8.0 Hz), 4.05–4.03 (m, 2H), 3.75 (t, 1H, J ꢀ=ꢀ 9.4 Hz), 0.83 (s, 9H);
mmol), appropriate [4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine NMR (CDCl ): δ 160.1, 156.8, 155.7, 152.6, 144.7, 139.9, 135.5, 135.3, 130.6,
C
3
1
-oxide (1.1 mmol), and K CO (415 mg, 3 mmol) were placed in 129.9, 129.3, 128.9, 128.4, 128.3, 127.6, 118.1, 117.1, 75.8, 68.9, 33.6, 25.8.
2 3
+
round-bottom flask. Then, freshly dried dioxane (16 mL) was added HRMS (ESI). Calcd for C H N O ([M+H] ): m/z 467.2190. Found m/z
2
7
27
6
2
and the mixture was heated at 95°C for 24 h. After cooling, the 467.2190.
solid material was filtered off and washed with CH Cl . The solvent
was evaporated, and the resulting crude product was purified as 2-(5,6-Diphenyl-1,2,4-triazin-3-ylamino)-3-[(4S)-4-phenyl-
described below.
2
2
4,5-dihydrooxazol-2-yl]pyridine 1-oxide (3b)ꢁCompound was
prepared from 3-[(4S)-4-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-
2
-[Bis(5,6-diphenyl-1,2,4-triazin-3-yl)amino]-3-[(4S)-4-tert-butyl- 2-amine 1-oxide (12b, 279 mg, 1.1 mmol); yield 10% (29 mg); mp 114–
,5-dihydro-1,3-oxazol-2-yl]pyridine 1-oxide (13a)ꢁCompound 115°C; [α]D2 ꢀ=ꢀ -16.2 (c 0.49, CH Cl ); IR (SnZe): 3059, 2918, 1643, 1600,
0
4
2
2
-1 1
was prepared from 3-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl] 1579, 1487, 1390, 1193, 1060, 694 cm ; H NMR (DMSO-d ): δ 10.01 (br
6
pyridine-2-amine 1-oxide (12a, 259 mg, 1.1 mmol), purified by silica s, 1H), 8.59 (dd, 1H, J ꢀ=ꢀ 1.4 Hz, J ꢀ=ꢀ 6.4 Hz), 7.85 (dd, 1H, J ꢀ=ꢀ 1.4 Hz, 8.0
gel chromatography (dichloromethane/methanol, 30:1) and crystal- Hz), 7.46–7.36 (m, 7H), 7.33–7.32 (m, 4H), 7.24–7.21 (m, 3H), 7.11–7.09 (m,
lized from hexanes/EtOAc; yield 35% (61 mg); mp 134–136°C; [α]D2 ꢀ=ꢀ 2H), 5.22 (dd, 1H, J ꢀ=ꢀ 8.8 Hz, J ꢀ=ꢀ 10.4 Hz), 4.61 (dd, 1H, J ꢀ=ꢀ 8.8 Hz, J ꢀ=ꢀ
0
1
3
-
1 7.0 ( c 0.61, CH Cl ); IR (KBr): 3059, 2956, 2868, 1651, 1517, 1490, 1398, 10.4 Hz), 3.76 (t, 1H, J ꢀ=ꢀ 8.8 Hz); C NMR (CDCl ): δ 161.8, 156.8, 156.0,
2
2
3
-1
1
1
1
365, 1280, 1062, 769, 696 cm ; H NMR (CDCl ): δ 8.43 (dd, 1H, J ꢀ=ꢀ 152.9, 144.3, 141.1, 139.5, 135.3, 135.1, 130.8, 129.8, 129.3, 129.1, 128.7,
3
.6 Hz, J ꢀ=ꢀ 6.8 Hz), 7.95 (dd, 1H, J ꢀ=ꢀ 1.6 Hz, J ꢀ=ꢀ 4.8 Hz), 7.54–7.47 (m, 128.4, 128.3, 128.1, 127.6, 126.4, 118.0, 74.5, 69.8. HRMS (ESI). Calcd for
+
9
H), 7.41–7.32 (m, 10H), 7.24–7.19 (m, 2H), 4.15 (dd, 1H, J ꢀ=ꢀ 8.6 Hz, J ꢀ=ꢀ C H N O ([M+H] ): m/z 487.1877. Found: m/z 487.1880.
29
23
6
2
1
0.0 Hz), 3.98 (t, 1H, J ꢀ=ꢀ 8.6 Hz), 3.85 (dd, 1H, J ꢀ=ꢀ 8.6 Hz, J ꢀ=ꢀ 10.0 Hz),
1
3
0
.61 (s, 9H); C NMR (CDCl ): δ 159.0, 158.9, 158.1, 156.7, 156.6, 153.9, 3-[(2S)-1-Chloro-3,3-dimethylbutan-2-ylcarbamoyl]-2-(5,6-diphe-
3
1
45.8, 141.1, 135.7, 135.6, 135.5, 135.4, 130.5, 130.4, 130.1, 130.0, 129.4, nyl-1,2,4-triazin-3-ylamino)pyridine 1-oxide (14a)ꢁCompound
1
29.1, 129.0, 128.4, 128.1, 127.2, 126.9, 124.0, 76.8, 33.6, 25.6. HRMS (ESI). was prepared from 3-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]
+
Calcd for C H N O ([M+H] ): m/z 698.2986. Found: m/z 698.2995.
pyridine-2-amine 1-oxide (12a, 259 mg, 1.1 mmol); yield 48% (255 mg);
42
36
9
2
Brought to you by | University of California - San Diego
Authenticated
Download Date | 3/23/16 9:37 AM